IRIS
PLANTONE, DOMENICO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.741
EU - Europa 3.694
AS - Asia 3.154
SA - Sud America 905
AF - Africa 312
OC - Oceania 8
Totale 11.814
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.655
SG - Singapore 1.130
RU - Federazione Russa 1.051
CN - Cina 779
BR - Brasile 744
IT - Italia 670
IE - Irlanda 659
VN - Vietnam 400
FR - Francia 317
HK - Hong Kong 302
SE - Svezia 289
GB - Regno Unito 196
ZA - Sudafrica 150
KR - Corea 134
DE - Germania 125
ES - Italia 105
FI - Finlandia 96
IN - India 89
NG - Nigeria 84
AR - Argentina 59
BD - Bangladesh 47
NL - Olanda 46
IQ - Iraq 45
ID - Indonesia 34
CA - Canada 33
EC - Ecuador 31
KE - Kenya 28
MX - Messico 28
SA - Arabia Saudita 26
TR - Turchia 25
AT - Austria 24
JP - Giappone 24
PK - Pakistan 18
BE - Belgio 17
CL - Cile 16
CO - Colombia 14
CZ - Repubblica Ceca 14
UA - Ucraina 13
PL - Polonia 12
PY - Paraguay 12
VE - Venezuela 11
LT - Lituania 10
AE - Emirati Arabi Uniti 8
CH - Svizzera 8
EG - Egitto 8
IR - Iran 8
MA - Marocco 8
TN - Tunisia 8
UZ - Uzbekistan 8
AL - Albania 7
AU - Australia 7
DZ - Algeria 7
JO - Giordania 7
PE - Perù 7
AZ - Azerbaigian 6
IL - Israele 6
KZ - Kazakistan 6
MY - Malesia 6
DK - Danimarca 5
HU - Ungheria 5
NP - Nepal 5
RO - Romania 5
TT - Trinidad e Tobago 5
UY - Uruguay 5
AM - Armenia 4
CI - Costa d'Avorio 4
PH - Filippine 4
PS - Palestinian Territory 4
PT - Portogallo 4
RS - Serbia 4
SN - Senegal 4
TH - Thailandia 4
BO - Bolivia 3
CR - Costa Rica 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
GE - Georgia 3
JM - Giamaica 3
LB - Libano 3
NI - Nicaragua 3
QA - Qatar 3
GT - Guatemala 2
GY - Guiana 2
KG - Kirghizistan 2
KW - Kuwait 2
LA - Repubblica Popolare Democratica del Laos 2
LV - Lettonia 2
MU - Mauritius 2
OM - Oman 2
SK - Slovacchia (Repubblica Slovacca) 2
SY - Repubblica araba siriana 2
TG - Togo 2
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BS - Bahamas 1
BW - Botswana 1
BY - Bielorussia 1
CG - Congo 1
CY - Cipro 1
Totale 11.796
Salva come PNG Salva come JPEG
Città #
Dallas 1.015
Dublin 643
Singapore 529
Chandler 378
Santa Clara 327
Hong Kong 290
Moscow 285
Hefei 219
Princeton 165
Beijing 164
Ashburn 144
Fairfield 143
Ho Chi Minh City 140
Johannesburg 140
Milan 134
Seoul 134
Council Bluffs 110
Hanoi 105
Lauterbourg 105
San Jose 94
Southend 88
Málaga 87
Wilmington 86
Los Angeles 85
Abuja 81
São Paulo 64
Helsinki 59
Siena 51
Redondo Beach 46
New York 45
Seattle 37
Buffalo 36
Woodbridge 35
Rome 34
Houston 33
San Diego 33
Ann Arbor 29
Bengaluru 29
Florence 29
Frankfurt am Main 29
Nuremberg 29
Lappeenranta 28
The Dalles 28
Cambridge 26
London 24
Munich 21
Orem 21
Baghdad 20
Lucca 20
Belo Horizonte 19
Riyadh 18
Pisa 17
Chennai 16
Haiphong 16
Brussels 14
Brno 13
Chicago 13
Messina 13
Naples 13
Quito 13
Rio de Janeiro 13
Shanghai 13
Tokyo 13
Toronto 13
Columbus 12
Nairobi 12
Biên Hòa 11
Brooklyn 11
Campinas 11
City of London 11
Da Nang 11
Goiânia 11
Guangzhou 11
Livorno 11
Porto Alegre 11
San Francisco 11
Atlanta 9
Basingstoke 9
Bologna 9
Curitiba 9
Phoenix 9
Brasília 8
Istanbul 8
Jakarta 8
Turku 8
Vienna 8
Warsaw 8
Amman 7
Aracaju 7
Carlentini 7
Fortaleza 7
Norwalk 7
Salvador 7
Sarzana 7
Stockholm 7
Tashkent 7
Thái Bình 7
Thái Nguyên 7
Tokushima 7
Uberlândia 7
Totale 7.032
Salva come PNG Salva come JPEG
Nome #
An atypical case of Creutzfeldt-Jakob disease mimicking frontotemporal dementia: genotypic influence and clinical implications 473
Brain neuronal and glial damage during acute COVID-19 infection in absence of clinical neurological manifestations 187
Neurofilament light chain and glial fibrillary acid protein levels are elevated in post-mild COVID-19 or asymptomatic SARS-CoV-2 cases 180
Hippocampal atrophy and white matter lesions characteristics can predict evolution to dementia in patients with vascular mild cognitive impairment 169
B Lymphocytes in Alzheimer's Disease-A Comprehensive Review 155
Regional hippocampal atrophy reflects memory impairment in patients with early relapsing remitting multiple sclerosis 147
A Systematic Review Focusing on the Link between Engineered Nanoparticles and Neurodegeneration 145
Neurological diseases associated with autoantibodies targeting the voltage-gated potassium channel complex: immunobiology and clinical characteristics 144
[18F]FDG PET metabolic correlates of cerebrospinal fluid TAR DNA-binding protein 43 in prodromal Alzheimer's disease 140
Acute Necrotizing Encephalopathy during Novel Influenza A (H1N1) Virus Infection 139
Comparative Analysis of SiMoA and Ella Immunoassay Platforms for Measuring Serum Neurofilament Light Chain Levels in ATTRv With Polyneuropathy and Presymptomatic Carriers 138
Elevated serum concentrations of GFAP in hereditary transthyretin amyloidosis since pre-symptomatic stages 136
Anorexia Heralding the Onset of Neuromyelitis Optica 133
Spinal cord atrophy as a primary outcome measure in phase II trials of progressive multiple sclerosis 130
A Perspective of Coagulation Dysfunction in Multiple Sclerosis and in Experimental Allergic Encephalomyelitis 130
Clinically relevant increases in serum neurofilament light chain and glial fibrillary acidic protein in patients with Susac syndrome 128
Peripherin, a new promising biomarker in neurological disorders 128
A neurometabolic profile of SPMS: the relationship between brain metabolites and clinical disability 127
Amiloride, Fluoxetine or Riluzole to Reduce Brain Volume Loss in Secondary Progressive Multiple Sclerosis: The MS-SMART Four-Arm RCT 126
Anti-annexin antibodies, cholesterol levels and disability in multiple sclerosis 126
Acute refractory intestinal pseudo-obstruction in MELAS : Efficacy of prucalopride 126
A voxel-based lesion symptom mapping analysis of chronic pain in multiple sclerosis 126
A Neurometabolic Profile of Secondary Progressive Multiple Sclerosis: The Relationship between Brain Metabolites and Clinical Disability 126
Serum growth differentiation factor-15, glial fibrillary acidic protein, and neurofilament light chain: Their link and role in Creutzfeldt-Jakob disease 124
Vitamin D in neurological diseases 124
Does Lumbar Puncture Still Have Clinical Value for Patients with Amyotrophic Lateral Sclerosis? 123
Atlantoaxial subluxation in rheumatoid arthritis 122
CSF IL-6, GDF-15, GFAP and NfL levels in early Alzheimer disease: a pilot study 121
Antiphospholipid antibodies: a possible biomarker of disease activity in multiple sclerosis and neuromyelitis optica spectrum disorders 121
A case of hemorrhagic Wernicke's encephalopathy following gastric surgery 120
Association between Anemia and Multiple Sclerosis 114
A longitudinal study of spinal cord atrophy in progressive multiple sclerosis 113
Interferon-beta therapy and risk of thrombocytopenia in multiple sclerosis patients 111
Clinical and biological underpinnings of longitudinal atrophy pattern progression in Alzheimer's disease 108
Investigating interleukin-8 in Alzheimer's disease: a comprehensive review 106
A new national survey of centers for cognitive disorders and dementias in Italy 106
Brainstem and spinal cord involvement in a paraneoplastic syndrome associated with anti-Yo antibody and breast cancer 104
Brain perfusion by arterial spin labeling MRI in multiple sclerosis 102
Efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis (MS-SMART): a phase 2b, multiarm, double-blind, randomised placebo-controlled trial 101
The Role of TNF-α in Alzheimer’s Disease: A Narrative Review 100
Clinical and MRI Predictors of Conversion From Mild Behavioural Impairment to Dementia 100
Systematic assessment and characterization of chronic pain in multiple sclerosis patients 100
CD4(+)T-bet(+), CD4(+)pSTAT3(+) and CD8(+)T-bet(+) T cells accumulate in peripheral blood during NZB treatment 98
Progress in the Treatment of Alzheimer’s Disease Is Needed – Position Statement of European Alzheimer’s Disease Consortium (EADC) Investigators 97
Current and Future Use of Chloroquine and Hydroxychloroquine in Infectious, Immune, Neoplastic, and Neurological Diseases: A Mini-Review 96
Second-line therapy with fingolimod for relapsing-remitting multiple sclerosis in clinical practice: the effect of previous exposure to natalizumab 96
Longitudinal Metabolite Changes in Progressive Multiple Sclerosis: A Study of 3 Potential Neuroprotective Treatments 95
CD8+effector and memory T cell subsets in relapsing-onset Multiple Sclerosis 95
Retinal nerve fibre layer thickness in the temporal quadrant predicts clinical disability and cervical cord cross sectional area in secondary progressive multiple sclerosis 95
Insights into the role of cerebrospinal fluid cytokines in Alzheimer's disease: A commentary on recent findings 93
CD8(+)Foxp3(+) T cells in peripheral blood of relapsing-remitting multiple sclerosis patients 93
Interferon-β therapy and risk of thrombocytopenia in multiple sclerosis patients 93
NAA is a Marker of Disability in Secondary-Progressive MS: A Proton MR Spectroscopic Imaging Study 93
HIV and lower risk of multiple sclerosis: role of adaptive immune response 93
Riboflavin in Neurological Diseases: A Narrative Review 93
Circulating CD56dim NK cells expressing perforin are increased in progressive multiple sclerosis 92
HIV and decreased risk of multiple sclerosis: role of low CD4+ lymphocyte count and male prevalence 92
Circulating CD8(+)CD56(-)perforin(+) T cells are increased in multiple sclerosis patients 92
Natural killer lymphocytes in HIV and multiple sclerosis 91
Is There a Role of Vitamin D in Alzheimer's disease? 90
Cerebellar degeneration associated with mGluR1 autoantibodies as a paraneoplastic manifestation of prostate adenocarcinoma 89
Tumefactive Demyelinating Lesions and Pregnancy 89
Brain reserve and physical disability in secondary progressive multiple sclerosis 88
Increased CD4(+)CD25(+)Foxp3(+) T cells in peripheral blood of celiac disease patients: Correlation with dietary treatment 88
Systematic assessment and characterization of chronic pain in multiple sclerosis patients 88
Paraneoplastic Morvan's syndrome following surgical treatment of recurrent thymoma: A case report 87
PPIs as possible risk factor for copper deficiency myelopathy 87
Paroxysmal ataxia and dysarthria in multiple sclerosis 87
Teaching NeuroImages: A case of hearing loss in a paraneoplastic syndrome associated with anti-Hu antibody 87
Initial cross-sectional MR spectroscopy analysis of a cohort of secondary progressive MS patients enrolled in the MS-SMART trial 87
Multiple Sclerosis Impact Scale and brain volume are independent predictors of cognitive impairment in Secondary Progressive Multiple Sclerosis 87
Current Evidence Supporting the Role of Immune Response in ATTRv Amyloidosis 86
Pharmacotherapy in Secondary Progressive Multiple Sclerosis: An Overview 86
Optical coherence tomography in secondary progressive multiple sclerosis: a baseline data report from the MS-SMART trial 86
Psychological General Well-being, Cognitive Failure, and Inflammation Biomarkers Among Workers 4 Months After a Mild/Asymptomatic SARS-CoV-2 Infection 85
Type 1 immune response in progressive multiple sclerosis 85
Osteoma of the Internal Auditory Canal 85
Teaching NeuroImages: Basal ganglia involvement in facio-brachial dystonic seizures associated with LGI1 antibodies 85
Examining cross-sectional relationships of optical coherence tomography, cervical cord MRI and disability in secondary progressive MS 85
Midbrain Panda Sign in a Patient with Wilsons Disease 84
Distinctive clinical and neuroimaging characteristics of longitudinally extensive transverse myelitis associated with aquaporin-4 autoantibodies 84
Concurrence of multiple sclerosis and brain tumors 84
Inflammatory profile in mitochondrial diseases: a cohort study 83
Reply [a: Influenza A (H1N1) in cerebrospinal fluid sample and encephalopathy by Sandoval-Gutiérrez JM, Arcos M, Alva L, Volkow P, T Ferrari T, Quiñones F, Vázquez-Pérez J, Ormsby JE, Hanssen F, Reséndiz A, Alcántara P, Pérez Padilla R, Bautista E] 83
Systematic assessment and characterization of chronic pain in multiple sclerosis patients: preliminary results 82
MTR-derived pial and subpial abnormalities in the spinal cord of RRMS patients: a two-year follow-up study 82
Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial (MS-SMART): a multiarm phase IIb randomised, double-blind, placebo-controlled clinical trial comparing the efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis 81
T-bet and pSTAT-1 expression in PBMC from coeliac disease patients: new markers of disease activity 81
Spinal cord area is a stronger predictor of physical disability than brain volume in secondary progressive Multiple Sclerosis 81
The detection of neural autoantibodies in patients with antiepileptic- drug-resistant epilepsy predicts response to immunotherapy 80
Commentary: Tumefactive Demyelinating Lesions as a First Clinical Event: Clinical, Imaging, and Follow-up Observations 79
Neuroimaging Correlates of Longitudinally Extensive Transverse Myelitis in AQP4-IgG Positive and AQP4-IgG Negative Patients 79
Secondary Progressive Multiple Sclerosis: Definition and Measurement 78
Neuroradiological characterization of multiple sclerosis patients with chronic pain 78
Neurofilament heavy chain in secondary progressive multiple sclerosis 77
Corrigendum: A Perspective of Coagulation Dysfunction in Multiple Sclerosis and in Experimental Allergic Encephalomyelitis 77
Dimethyl fumarate may still have a role in progressive multiple sclerosis 76
Tissue-infiltrating lymphocytes analysis reveals large modifications of the duodenal "immunological niche" in coeliac disease after gluten-free diet 75
Vascular risk factors are associated with grey matter atrophy in secondary progressive multiple sclerosis 74
Spinal Cord Atrophy in Multiple sclerosis 74
Totale 10.685
Salva come PNG Salva come JPEG
Categoria #
all - tutte 48.278
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.278
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.132 0 0 290 214 59 22 7 90 43 29 76 302
2022/20231.358 133 129 174 170 81 249 45 82 152 94 24 25
2023/2024840 44 28 35 21 18 223 288 14 5 18 20 126
2024/20252.629 88 148 170 133 279 156 53 143 211 173 256 819
2025/20266.251 488 948 1.053 852 1.021 209 735 304 298 343 0 0
Totale 12.210